Cell proliferation of human ovarian cancer is regulated by the opioid growth factor-opioid growth factor receptor axis.
about
Current research on opioid receptor function.Peripheral opioid antagonist enhances the effect of anti-tumor drug by blocking a cell growth-suppressive pathway in vivoTopical Naltrexone as Treatment for Type 2 Diabetic Cutaneous WoundsInhibition of DNA synthesis in mouse epidermis by topical imiquimod is dependent on opioid receptors.Regulation of Tenon's capsule fibroblast cell proliferation by the opioid growth factor and the opioid growth factor receptor axis.Opioids, Neutral Endopeptidase, its Inhibitors and Cancer: Is There a Relationship among them?Synergistic effect of aged garlic extract and naltrexone on improving immune responses to experimentally induced fibrosarcoma tumor in BALB/c miceInternalization of the opioid growth factor, [Met5]-enkephalin, is dependent on clathrin-mediated endocytosis for downregulation of cell proliferationSynergistic effect of methionine encephalin (MENK) combined with pidotimod(PTD) on the maturation of murine dendritic cells (DCs)RNA interference and ovarian functions.Inhibition of the growth of human melanoma cells by methionine enkephalin.Opioid growth factor - opioid growth factor receptor axis inhibits proliferation of triple negative breast cancer.Macrophage polarization induced by neuropeptide methionine enkephalin (MENK) promotes tumoricidal responses.Under-expression of the opioid growth factor receptor promotes progression of human ovarian cancer.Low-dose naltrexone targets the opioid growth factor-opioid growth factor receptor pathway to inhibit cell proliferation: mechanistic evidence from a tissue culture model.Low-dose naltrexone suppresses ovarian cancer and exhibits enhanced inhibition in combination with cisplatin.Opioid growth factor-opioid growth factor receptor axis is a physiological determinant of cell proliferation in diverse human cancers.Passive diffusion of naltrexone into human and animal cells and upregulation of cell proliferation.Naltrexone Inhibits IL-6 and TNFα Production in Human Immune Cell Subsets following Stimulation with Ligands for Intracellular Toll-Like Receptors.Methionine enkephalin (MENK) improves lymphocyte subpopulations in human peripheral blood of 50 cancer patients by inhibiting regulatory T cells (Tregs).Integrated proteomic and transcriptomic analysis revealslong noncoding RNA HOTAIR promotes hepatocellular carcinoma cell proliferation by regulating opioid growth factor receptor (OGFr).Selective blockade of the OGF-OGFr pathway by naltrexone accelerates fibroblast proliferation and wound healing.Targeted overexpression of OGFr in epithelium of transgenic mice suppresses cell proliferation and impairs full-thickness wound closure.Novel treatment for triple-negative breast and ovarian cancer: endogenous opioid suppression of women's cancers.Topical Naltrexone Is a Safe and Effective Alternative to Standard Treatment of Diabetic Wounds.Androgen represses opioid growth factor receptor (OGFR) in human prostate cancer LNCaP cells and OGFR expression in human prostate cancer tissueThe novel mechanism of anticancer effect on gastric cancer through inducing G0/G1 cell cycle arrest and caspase-dependent apoptosis in vitro and in vivo by methionine enkephalin
P2860
Q27693220-41AF4236-6C10-49E1-99E3-4865577EB6F2Q28545949-123F9AD7-1822-4EB4-875A-0D398CE422CEQ33724491-FE4987E2-3012-4309-B2C0-7DB8074DA1FAQ34624683-A8344934-8832-4F1F-A706-0E47506822D0Q34735305-C8537A0D-C256-4420-9528-BADC76990D01Q35598669-DB98300F-60E2-469A-AEF6-85EAD6D04457Q37035022-1876A9AF-ABA3-4A06-BD44-583FA4DF5AF5Q37174499-38725E27-EDED-44A6-8E74-AB5B674634F4Q37521866-0A27A728-1FCE-4729-A09C-035F67DBCAC5Q37766809-439F9898-7112-446E-8B92-6D34EC331958Q38729547-5E52CDCD-2577-4721-BB6E-07A76F655825Q39114818-C31D656F-86F9-4673-B702-D3108510BBD2Q39379509-5CBC309C-845D-4E4E-88B5-0A16D742C518Q39397468-2A731579-B00C-4C60-9AE5-13B759D73026Q39496812-AE664F0B-DA35-44DD-AD87-288F42959A90Q39522079-77FDE50A-53E6-49E1-B9C9-138BF3BB8602Q39813287-56ED6769-E057-4EBD-95A7-B3963332414BQ39824856-2FCA8C8C-134E-4854-A3E8-15EDCC93B632Q40119691-2A604151-70CE-407E-AC11-A082E8F0221EQ41807400-9BAEFF19-C7A6-467F-8210-E1EFEBD34CBDQ42778320-7A0BA250-23AB-4CA6-8A95-1EC3457EE1AFQ42799555-BAA5780D-4BA4-43E1-A276-D81D234BA8F9Q44031670-60539C93-DC3D-48E9-A87F-57EE3109227FQ44342789-9E35DC26-BF78-47E1-B444-DC87D669E197Q50144166-58F543C3-F4F1-4BF6-9DC4-9EA0CD85B7ABQ57135037-DD4757E8-9011-4C3D-8E47-F0B0D455EFBBQ58694707-4AA33E2E-31BE-4FF5-9EC5-0A94739C41F6
P2860
Cell proliferation of human ovarian cancer is regulated by the opioid growth factor-opioid growth factor receptor axis.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Cell proliferation of human ov ...... d growth factor receptor axis.
@ast
Cell proliferation of human ov ...... d growth factor receptor axis.
@en
Cell proliferation of human ov ...... d growth factor receptor axis.
@nl
type
label
Cell proliferation of human ov ...... d growth factor receptor axis.
@ast
Cell proliferation of human ov ...... d growth factor receptor axis.
@en
Cell proliferation of human ov ...... d growth factor receptor axis.
@nl
prefLabel
Cell proliferation of human ov ...... d growth factor receptor axis.
@ast
Cell proliferation of human ov ...... d growth factor receptor axis.
@en
Cell proliferation of human ov ...... d growth factor receptor axis.
@nl
P2093
P2860
P1476
Cell proliferation of human ov ...... d growth factor receptor axis.
@en
P2093
Ian S Zagon
Patricia J McLaughlin
Renee N Donahue
P2860
P304
P356
10.1152/AJPREGU.00075.2009
P577
2009-03-18T00:00:00Z